Cytomegalovirus vaccine

Cytomegalovirus vaccine is a type of vaccine that is currently under development to protect against the disease caused by the cytomegalovirus (CMV). CMV is a common virus that can infect people of all ages. Most people don't know they have CMV because it rarely causes symptoms. However, if you're pregnant or have a weakened immune system, CMV is cause for concern.

Overview

CMV is a member of the herpesvirus family. It is common and typically harmless to the general population, but can cause severe illness in people with weak immune systems and in newborns infected before birth. A CMV vaccine could potentially prevent these problems.

Development

Several CMV vaccines are currently in the experimental stages of development. These vaccines are being designed to stimulate an immune response to CMV, which would prevent or reduce the severity of disease caused by this virus.

Clinical Trials

Several clinical trials have been conducted to test the safety and efficacy of CMV vaccines. These trials are an important step in the development process, as they provide the necessary data to determine whether a vaccine is safe and effective.

Potential Benefits

A successful CMV vaccine could have several potential benefits. It could reduce the number of babies born with congenital CMV, which is the most common viral cause of birth defects and developmental disabilities. It could also protect people with weakened immune systems, such as organ transplant recipients and people with HIV/AIDS.

See Also

• Vaccine
• Cytomegalovirus
• Herpesviridae
• Clinical trial